呼吸道细菌检查结果对慢性肺曲霉菌病患者的影响。

IF 2.8 Q3 MICROBIOLOGY International Journal of Microbiology Pub Date : 2024-04-30 eCollection Date: 2024-01-01 DOI:10.1155/2024/1329884
Hyun Kyu Cho, Seong Mi Moon, Hyoung-Tae Kim, Beomsu Shin
{"title":"呼吸道细菌检查结果对慢性肺曲霉菌病患者的影响。","authors":"Hyun Kyu Cho, Seong Mi Moon, Hyoung-Tae Kim, Beomsu Shin","doi":"10.1155/2024/1329884","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Distinct bacterial strains may affect the prognosis of patients with chronic respiratory diseases. However, little is known about the clinical significance of respiratory bacteria in patients with chronic pulmonary aspergillosis (CPA), a progressive and debilitating disease caused by <i>Aspergillus</i> spp.</p><p><strong>Objectives: </strong>This study aimed to analyze data obtained from CPA patients and their sputum or bronchial washing samples and investigate the prevalence and composition of respiratory bacteria and clinical implications. <i>Patients and Methods</i>. We retrospectively reviewed the data of patients diagnosed with CPA between March 2019 and February 2023 in a tertiary referral hospital. We assessed the clinical characteristics and overall and pneumonia-specific survival rates of patients with CPA based on the presence of bacteria. <i>Results and Conclusion</i>s. We included 142 patients with CPA. The most commonly identified bacteria were <i>Klebsiella pneumoniae</i> (22.5%), followed by <i>Pseudomonas aeruginosa</i> (21.8%) and <i>Escherichia coli</i> (4.2%). Patients with isolated bacteria had a higher prevalence of older age, female sex, diabetes, and a history of extrathoracic malignancy than those without isolated bacteria (<i>P</i> = 0.024, 0.013, 0.021, and 0.034, respectively). Furthermore, over a median follow-up of 11 (4-21) months, the pneumonia-specific mortality rate was 13.4% (19/142), which was higher in patients with isolated bacteria than in those without (<i>P</i> = 0.045, log-rank test). Particularly, patients with the presence of <i>P. aeruginosa</i> had a significantly higher mortality rate from pneumonia than those without the presence of <i>P. aeruginosa</i> (adjusted hazard ratio, 3.34; <i>P</i> = 0.015). In conclusion, CPA patients with isolated bacteria, especially <i>P. aeruginosa</i>, showed higher mortality rates due to pneumonia. Performing tests to identify bacteria in the lower respiratory tract of patients with CPA may be helpful in predicting future prognosis. Further studies are required to validate these findings in diverse ethnic groups.</p>","PeriodicalId":14098,"journal":{"name":"International Journal of Microbiology","volume":null,"pages":null},"PeriodicalIF":2.8000,"publicationDate":"2024-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11074846/pdf/","citationCount":"0","resultStr":"{\"title\":\"Impact of Respiratory Bacterial Findings on Patients with Chronic Pulmonary Aspergillosis.\",\"authors\":\"Hyun Kyu Cho, Seong Mi Moon, Hyoung-Tae Kim, Beomsu Shin\",\"doi\":\"10.1155/2024/1329884\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Distinct bacterial strains may affect the prognosis of patients with chronic respiratory diseases. However, little is known about the clinical significance of respiratory bacteria in patients with chronic pulmonary aspergillosis (CPA), a progressive and debilitating disease caused by <i>Aspergillus</i> spp.</p><p><strong>Objectives: </strong>This study aimed to analyze data obtained from CPA patients and their sputum or bronchial washing samples and investigate the prevalence and composition of respiratory bacteria and clinical implications. <i>Patients and Methods</i>. We retrospectively reviewed the data of patients diagnosed with CPA between March 2019 and February 2023 in a tertiary referral hospital. We assessed the clinical characteristics and overall and pneumonia-specific survival rates of patients with CPA based on the presence of bacteria. <i>Results and Conclusion</i>s. We included 142 patients with CPA. The most commonly identified bacteria were <i>Klebsiella pneumoniae</i> (22.5%), followed by <i>Pseudomonas aeruginosa</i> (21.8%) and <i>Escherichia coli</i> (4.2%). Patients with isolated bacteria had a higher prevalence of older age, female sex, diabetes, and a history of extrathoracic malignancy than those without isolated bacteria (<i>P</i> = 0.024, 0.013, 0.021, and 0.034, respectively). Furthermore, over a median follow-up of 11 (4-21) months, the pneumonia-specific mortality rate was 13.4% (19/142), which was higher in patients with isolated bacteria than in those without (<i>P</i> = 0.045, log-rank test). Particularly, patients with the presence of <i>P. aeruginosa</i> had a significantly higher mortality rate from pneumonia than those without the presence of <i>P. aeruginosa</i> (adjusted hazard ratio, 3.34; <i>P</i> = 0.015). In conclusion, CPA patients with isolated bacteria, especially <i>P. aeruginosa</i>, showed higher mortality rates due to pneumonia. Performing tests to identify bacteria in the lower respiratory tract of patients with CPA may be helpful in predicting future prognosis. Further studies are required to validate these findings in diverse ethnic groups.</p>\",\"PeriodicalId\":14098,\"journal\":{\"name\":\"International Journal of Microbiology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":2.8000,\"publicationDate\":\"2024-04-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11074846/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Microbiology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1155/2024/1329884\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q3\",\"JCRName\":\"MICROBIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Microbiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/2024/1329884","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

背景:不同的细菌菌株可能会影响慢性呼吸道疾病患者的预后。然而,人们对慢性肺曲霉菌病(CPA)患者呼吸道细菌的临床意义知之甚少:本研究旨在分析从 CPA 患者及其痰液或支气管冲洗样本中获得的数据,并调查呼吸道细菌的流行率、组成及临床意义。患者和方法。我们回顾性回顾了2019年3月至2023年2月期间在一家三级转诊医院确诊为CPA患者的数据。我们根据细菌的存在情况评估了 CPA 患者的临床特征、总体存活率和肺炎特异性存活率。结果与结论。我们纳入了 142 名 CPA 患者。最常发现的细菌是肺炎克雷伯菌(22.5%),其次是铜绿假单胞菌(21.8%)和大肠埃希菌(4.2%)。与无细菌分离的患者相比,有细菌分离的患者中年龄较大、女性、糖尿病和胸外恶性肿瘤病史的比例更高(P = 0.024、0.013、0.021 和 0.034)。此外,在中位随访 11(4-21)个月期间,肺炎特异性死亡率为 13.4%(19/142),有分离细菌的患者高于无分离细菌的患者(P = 0.045,对数秩检验)。尤其是,存在铜绿假单胞菌的患者的肺炎死亡率明显高于不存在铜绿假单胞菌的患者(调整后危险比为 3.34;P = 0.015)。总之,分离出细菌(尤其是铜绿假单胞菌)的 CPA 患者因肺炎导致的死亡率较高。对 CPA 患者的下呼吸道细菌进行检测可能有助于预测未来的预后。要在不同种族群体中验证这些发现,还需要进一步的研究。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Impact of Respiratory Bacterial Findings on Patients with Chronic Pulmonary Aspergillosis.

Background: Distinct bacterial strains may affect the prognosis of patients with chronic respiratory diseases. However, little is known about the clinical significance of respiratory bacteria in patients with chronic pulmonary aspergillosis (CPA), a progressive and debilitating disease caused by Aspergillus spp.

Objectives: This study aimed to analyze data obtained from CPA patients and their sputum or bronchial washing samples and investigate the prevalence and composition of respiratory bacteria and clinical implications. Patients and Methods. We retrospectively reviewed the data of patients diagnosed with CPA between March 2019 and February 2023 in a tertiary referral hospital. We assessed the clinical characteristics and overall and pneumonia-specific survival rates of patients with CPA based on the presence of bacteria. Results and Conclusions. We included 142 patients with CPA. The most commonly identified bacteria were Klebsiella pneumoniae (22.5%), followed by Pseudomonas aeruginosa (21.8%) and Escherichia coli (4.2%). Patients with isolated bacteria had a higher prevalence of older age, female sex, diabetes, and a history of extrathoracic malignancy than those without isolated bacteria (P = 0.024, 0.013, 0.021, and 0.034, respectively). Furthermore, over a median follow-up of 11 (4-21) months, the pneumonia-specific mortality rate was 13.4% (19/142), which was higher in patients with isolated bacteria than in those without (P = 0.045, log-rank test). Particularly, patients with the presence of P. aeruginosa had a significantly higher mortality rate from pneumonia than those without the presence of P. aeruginosa (adjusted hazard ratio, 3.34; P = 0.015). In conclusion, CPA patients with isolated bacteria, especially P. aeruginosa, showed higher mortality rates due to pneumonia. Performing tests to identify bacteria in the lower respiratory tract of patients with CPA may be helpful in predicting future prognosis. Further studies are required to validate these findings in diverse ethnic groups.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
7.90
自引率
0.00%
发文量
57
审稿时长
13 weeks
期刊介绍: International Journal of Microbiology is a peer-reviewed, Open Access journal that publishes original research articles, review articles, and clinical studies on microorganisms and their interaction with hosts and the environment. The journal covers all microbes, including bacteria, fungi, viruses, archaea, and protozoa. Basic science will be considered, as well as medical and applied research.
期刊最新文献
Bacteriuria Among Type 2 Diabetes Mellitus Patients Attending Ejisu Government Hospital in the Ashanti Region, Ghana. Penicillium citrinum CFAM 521 Isolated From the Amazon Region: A Novel Source of a Fibrinolytic Enzyme. Comprehensive Genome Analysis of Colistin-Only-Sensitive KPC-2 and NDM1-1-Coproducing Klebsiella pneumoniae ST11 and Acinetobacter baumannii ST2 From a Critically Ill Patient With COVID-19 in Saudi Arabia: Whole Genome Sequencing (WGS) of K. pneumoniae ST11 and A. baumannii ST2. Potential Target Metabolites From Gut Microbiota Against Hepatocellular Carcinoma: A Network Pharmacology and Molecular Docking Study. Determination of Biodegradation Potential of Aspergillus niger, Candida albicans, and Acremonium sclerotigenum on Polyethylene, Polyethylene Terephthalate, and Polystyrene Microplastics.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1